This market is expected to grow at a 4.9% CAGR between 2023 and 2033 for atypical hemolytic uremic syndrome (ahus) treatment market, according to Future Market Insights. By 2033, it is estimated that the market for treatments for Atypical Hemolytic Uremic Syndrome (Ahus) would be valued US$ 2308.84 million. A number of factors are driving the growth of this market, including rising rates...